QIAGEN announced that most recently serving as Senior Vice President, Head of Corporate Business Development and Intellectual Property & Litigation and member of the Executive Committee, Dr. Ulrich Schriek has decided to take on a new role as of May 20, 2015, as Senior Advisor to the CEO of QIAGEN. Jean-Pascal Viola, who is currently Vice President, Global Head of M&A and Corporate Ventures, has been appointed Senior Vice President, Head of Corporate Business Development and Intellectual Property & Litigation, reporting to Peer M. Schatz.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.37 USD | +0.66% | -1.05% | -7.49% |
06-27 | Wolfe Research Upgrades Qiagen to Outperform From Peer Perform, Price Target is $50 | MT |
06-21 | Qiagen Seeks M&A | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.49% | 9.12B | |
+39.04% | 39.1B | |
-7.41% | 38.76B | |
+27.72% | 31.24B | |
+13.03% | 25.9B | |
-13.75% | 25.8B | |
+46.04% | 14.06B | |
+39.15% | 13.12B | |
-6.38% | 11.32B | |
-11.59% | 10.68B |
- Stock Market
- Equities
- QGEN Stock
- News Qiagen N.V.
- Qiagen Announces Executive Changes